Skip to main content

Peer Review reports

From: Investigating the efficacy of baricitinib in new onset type 1 diabetes mellitus (BANDIT)—study protocol for a phase 2, randomized, placebo controlled trial

Original Submission
27 Jan 2022 Submitted Original manuscript
2 Feb 2022 Reviewed Reviewer Report - Kirsty Loudon
8 Mar 2022 Author responded Author comments - Michaela Waibel
Resubmission - Version 2
8 Mar 2022 Submitted Manuscript version 2
Publishing
25 Apr 2022 Editorially accepted
23 May 2022 Article published 10.1186/s13063-022-06356-z

You can find further information about peer review here.

Back to article page

Trials

ISSN: 1745-6215